{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:01:16Z","timestamp":1791460876977,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.19090\\u201339"],"award-info":[{"award-number":["320.6750.19090\\u201339"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8196068 0"],"award-info":[{"award-number":["8196068 0"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960646"],"award-info":[{"award-number":["81960646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373494"],"award-info":[{"award-number":["81373494"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81641142"],"award-info":[{"award-number":["81641142"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702853"],"award-info":[{"award-number":["81702853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007764","name":"Lanzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["2017-RC-61"],"award-info":[{"award-number":["2017-RC-61"]}],"id":[{"id":"10.13039\/501100007764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006765","name":"Chinese Medical Association","doi-asserted-by":"publisher","award":["320.6750.19090"],"award-info":[{"award-number":["320.6750.19090"]}],"id":[{"id":"10.13039\/501100006765","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejphar.2020.173498","type":"journal-article","created":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T19:22:22Z","timestamp":1598124142000},"page":"173498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo"],"prefix":"10.1016","volume":"885","author":[{"given":"Guoqiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A'xi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin'an","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173498_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.toxlet.2011.10.023","article-title":"Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation","volume":"208","author":"Ahmad","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejphar.2020.173498_bib2","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1080\/14656566.2016.1218471","article-title":"Obeticholic acid for the treatment of primary biliary cholangitis","volume":"17","author":"Ali","year":"2016","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2020.173498_bib3","series-title":"Oral Administration of Hesperidin, a Citrus Flavonone, in Rats Counteracts the Oxidative Stress, the Inflammatory Cytokine Production, and the Hepatotoxicity Induced by the Ingestion of 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD)","first-page":"91","volume":"24","author":"Bentli","year":"2013"},{"key":"10.1016\/j.ejphar.2020.173498_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bjp.2014.07.011","article-title":"Ulcer protective potential of standardized hesperidin, a citrus flavonoid isolated from Citrus sinensis","volume":"24","author":"Bigoniya","year":"2014","journal-title":"Rev. bras. farmacogn."},{"key":"10.1016\/j.ejphar.2020.173498_bib5","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ptr.6406","article-title":"Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled, double-blind clinical trial","volume":"33","author":"Cheraghpour","year":"2019","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2020.173498_bib6","doi-asserted-by":"crossref","first-page":"114666","DOI":"10.1016\/j.taap.2019.114666","article-title":"Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG(R) cells","volume":"379","author":"Cuykx","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173498_bib7","doi-asserted-by":"crossref","first-page":"116638","DOI":"10.1016\/j.lfs.2019.116638","article-title":"Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf 15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats","volume":"232","author":"Duan","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2020.173498_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040783","article-title":"Protective effect of hesperidin on the oxidative stress induced by an exhausting exercise in intensively trained rats","volume":"11","author":"Estruel-Amades","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2020.173498_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173498_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bcp.2017.09.016","article-title":"Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury","volume":"146","author":"Gao","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173498_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2018.04.015","article-title":"Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro","volume":"348","author":"Gao","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173498_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030648","article-title":"Hesperidin as a neuroprotective agent: a review of animal and clinical evidence","volume":"24","author":"Hajialyani","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2020.173498_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173498_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tiv.2018.08.001","article-title":"The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity","volume":"53","author":"Kamalian","year":"2018","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2020.173498_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tox.2006.06.018","article-title":"Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity","volume":"226","author":"Kaur","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2020.173498_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/164_2019_231","article-title":"Targeting FXR in cholestasis","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173498_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0065-2571(99)00022-9","article-title":"Localization, substrate specificity, and drug resistance conferred by conjugate export pumps of the MRP family","volume":"40","author":"Keppler","year":"2000","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejphar.2020.173498_bib18","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1194\/jlr.M700330-JLR200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine","volume":"48","author":"Kim","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2020.173498_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nu11020257","article-title":"Hop compounds: extraction techniques, chemical analyses, antioxidative, antimicrobial, and anticarcinogenic effects","volume":"11","author":"Knez Hrncic","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2020.173498_bib20","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0168-8278(03)00397-0","article-title":"ABC transporter regulation by bile acids: where PXR meets FXR","volume":"39","author":"Kullak-Ublick","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173498_bib21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2003.06.005","article-title":"Enterohepatic bile salt transporters in normal physiology and liver disease","volume":"126","author":"Kullak-Ublick","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173498_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-016-0616-x","article-title":"Obeticholic acid: first global approval","volume":"76","author":"Markham","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2020.173498_bib23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.23876","article-title":"Liver X receptor alpha and farnesoid X receptor are major transcriptional regulators of OATP1B1","volume":"52","author":"Meyer Zu Schwabedissen","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173498_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.20295","article-title":"Bile acid-induced negative feedback regulation of the human ileal bile acid transporter","volume":"40","author":"Neimark","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2020.173498_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1053\/j.gastro.2015.02.037","article-title":"Targeting the FXR nuclear receptor to treat liver disease","volume":"148","author":"Neuschwander-Tetri","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2020.173498_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuroscience.2013.09.030","article-title":"Hesperidin pretreatment protects hypoxia-ischemic brain injury in neonatal rat","volume":"255","author":"Rong","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173498_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173498_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.xphs.2016.01.013","article-title":"Establishment of a drug-induced, bile acid-dependent hepatotoxicity model using HepaRG cells","volume":"105","author":"Susukida","year":"2016","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2020.173498_bib29","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-019-38668-7","article-title":"Identification of FDA-approved drugs targeting the farnesoid X receptor","volume":"9","author":"van de Wiel","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173498_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","article-title":"FXR modulators for enterohepatic and metabolic diseases","volume":"28","author":"Wang","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2020.173498_bib31","series-title":"Evidence-based Complementary and Alternative Medicine : eCAM","first-page":"1640187","article-title":"Upregulation of PDZK1 by calculus bovis sativus may play an important role in restoring biliary transport function in intrahepatic cholestasis","volume":"2017","author":"Xiang","year":"2017"},{"key":"10.1016\/j.ejphar.2020.173498_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/jbt.21799","article-title":"Hesperidin alleviates oxidative stress and upregulates the multidrug resistance protein 2 in isoniazid and rifampicin-induced liver injury in rats","volume":"30","author":"Zhang","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173498_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/aps.2017.98","article-title":"D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress","volume":"39","author":"Zhao","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2020.173498_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","article-title":"Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations","volume":"3","author":"Zollner","year":"2006","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920305902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:57:31Z","timestamp":1777402651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920305902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":34,"alternative-id":["S0014299920305902"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173498","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hesperidin alleviates cholestasis via activation of the farnesoid X receptor in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173498"}}